October 11th 2016
NZ Society of Naturopaths Urges Medsafe to
Ban Diabetes Drug Avandia
The New Zealand Society of Naturopaths
Media Release 25th September 2010
by Jaine Kirtley PR Spokesperson for NZSN
The NZ Society of Naturopaths urges Medsafe to ban the diabetes drug Avandia.
Avandia (rosiglitazone) which is used to treat Type 2 Diabetes has just been banned by the European Medicines Agency (EMA).
Avandia has always been known to cause fluid retention and increased risk of heart failure; so the drug makers cautioned doctors not to prescribe it for people with Type 2 Diabetes who also have cardiovascular disease. However, now recent in-depth analysis of scientific studies by the EMA (including clinical trials, observational studies and meta-analyses) has shown a possible increased risk of ischaemic heart disease associated with the use of rosiglitazone and led the EMA to state that the benefits of rosiglitazone (Avandia) no longer outweigh its risks.
Type 2 Diabetes is a growing and sometimes debilitating condition affecting 270,000 people in New Zealand today. The inappropriate diets and lifestyles that predominately lead to Type 2 Diabetes can also cause cardiovascular disease. In addition, cardiovascular problems are directly caused by high blood sugar levels which occur in diabetes. Therefore, the NZSN believe that Avandia should not be used and call on the government to ban it in New Zealand.
The NZ Society of Naturopaths believes that the dietary and lifestyle advice and support given to people with Type 2 diabetes by government health care agencies is inadequate, and that there is an over reliance on medication to control symptoms. Its a bit like telling someone with lung cancer that they only need to cut down on smoking rather than giving them the clear hard line message that they have to stop smoking altogether said a NZSN spokesperson. Naturopaths focus on addressing the underlying cause of disease; diet and lifestyle are aspects that are always addressed, not only in Type 2 Diabetes but all other conditions.
Further information available at:
http://www.diabetes.org.nz/about_diabetes/type_2_diabetes
http://www.medsafe.govt.nz/profs/PUArticles/RosiglitazoneAndSept10.htm
http://www.medsafe.govt.nz/profs/datasheet/a/Avandiatab.pdf
Please click here to add text and other content
Please click here to add text and other content